{"transactions":[{"id":737901,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":38203,"kind":"person","name":"MCCOLLUM JAMES W","position":1,"cik":"0001200889","reported_name":"MCCOLLUM JAMES W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-16T00:18:12.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":22100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's Outside Director Compensation Policy) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier to occur of June 15, 2027 or the date of the next annual meeting of stockholders."}],"balance_after":22100,"derivative":{"exercise_price":6.63,"expiration_date":"2036-06-15","underlying":"Common Stock","underlying_shares":22100},"source":{"system":"sec-edgar","filing":"0001200889-26-000001","document":"wk-form4_1781569089.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000120088926000001/wk-form4_1781569089.xml","form_type":"4"}},{"id":1003806,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":38203,"kind":"person","name":"MCCOLLUM JAMES W","position":1,"cik":"0001200889","reported_name":"MCCOLLUM JAMES W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-10T21:13:53.000Z","date":"2025-11-07","kind":"purchase","planned":false,"acquired":true,"shares":10500,"price":22.7884,"value":239278.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 10,500 shares purchased in the price range of $22.68 to $22.87 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":10500,"source":{"system":"sec-edgar","filing":"0001815776-25-000073","document":"wk-form4_1762809230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577625000073/wk-form4_1762809230.xml","form_type":"4"}},{"id":1115127,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":38203,"kind":"person","name":"MCCOLLUM JAMES W","position":1,"cik":"0001200889","reported_name":"MCCOLLUM JAMES W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-11T21:46:02.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be an Outside Director (as defined in the Issuer's Outside Director Compensation Policy) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on June 11, 2026."}],"balance_after":13500,"derivative":{"exercise_price":30,"expiration_date":"2035-06-10","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001815776-25-000044","document":"wk-form4_1749678354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577625000044/wk-form4_1749678354.xml","form_type":"4"}},{"id":1517663,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":38203,"kind":"person","name":"MCCOLLUM JAMES W","position":1,"cik":"0001200889","reported_name":"MCCOLLUM JAMES W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-14T21:29:43.000Z","date":"2024-05-13","kind":"purchase","planned":false,"acquired":true,"shares":31332,"price":15.993,"value":501092.676,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 31,332 shares purchased in the price range of $15.96 to $16.00 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":525565,"source":{"system":"sec-edgar","filing":"0001815776-24-000044","document":"wk-form4_1715722170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000044/wk-form4_1715722170.xml","form_type":"4"}},{"id":1561974,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":38203,"kind":"person","name":"MCCOLLUM JAMES W","position":1,"cik":"0001200889","reported_name":"MCCOLLUM JAMES W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-26T00:42:24.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean March 21, 2024."}],"balance_after":27000,"derivative":{"exercise_price":15.05,"expiration_date":"2034-03-20","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001815776-24-000028","document":"wk-form4_1711413733.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000028/wk-form4_1711413733.xml","form_type":"4"}},{"id":1561973,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":38203,"kind":"person","name":"MCCOLLUM JAMES W","position":1,"cik":"0001200889","reported_name":"MCCOLLUM JAMES W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2024-03-26T00:42:24.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":6575,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"Warrant assumed in connection with the closing of the transactions contemplated by the Merger Agreement, in exchange of an outstanding warrant to purchase shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement."}],"balance_after":6575,"derivative":{"exercise_price":10.64,"exercise_date":"2020-10-30","expiration_date":"2027-10-30","underlying":"Common Stock","underlying_shares":6575},"source":{"system":"sec-edgar","filing":"0001815776-24-000028","document":"wk-form4_1711413733.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000028/wk-form4_1711413733.xml","form_type":"4"}},{"id":1561972,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":38203,"kind":"person","name":"MCCOLLUM JAMES W","position":1,"cik":"0001200889","reported_name":"MCCOLLUM JAMES W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-26T00:42:24.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":16633,"price":15.0299,"value":249992.3267,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares issued upon the closing of the private placement financing under the Subscription Agreement by and among the Issuer, the Reporting Person and the other purchasers party thereto, dated as of November 14, 2023, pursuant to which, immediately following the closing of the transactions contemplated by the Merger Agreement, such purchasers purchased an aggregate of 3,559,565 shares of Common Stock at a price of $15.0299 per share for aggregate gross proceeds to the Issuer of approximately $53.5 million, as more fully described in the Issuer's reports filed with the Securities and Exchange Commission."}],"balance_after":494233,"source":{"system":"sec-edgar","filing":"0001815776-24-000028","document":"wk-form4_1711413733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000028/wk-form4_1711413733.xml","form_type":"4"}},{"id":1561971,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":38203,"kind":"person","name":"MCCOLLUM JAMES W","position":1,"cik":"0001200889","reported_name":"MCCOLLUM JAMES W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-26T00:42:24.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":477600,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2023 (the \"Merger Agreement\"), by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the issuer, and LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.), a Delaware corporation (\"LENZ OpCo\"), in exchange of outstanding shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement."}],"balance_after":477600,"source":{"system":"sec-edgar","filing":"0001815776-24-000028","document":"wk-form4_1711413733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000028/wk-form4_1711413733.xml","form_type":"4"}},{"id":1561970,"issuer":{"id":6475,"kind":"organization","name":"LENZ Therapeutics, Inc."},"owners":[{"id":38203,"kind":"person","name":"MCCOLLUM JAMES W","position":1,"cik":"0001200889","reported_name":"MCCOLLUM JAMES W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-26T00:42:24.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":95034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Shares issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of November 14, 2023 (the \"Merger Agreement\"), by and among the Issuer, Generate Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the issuer, and LENZ Therapeutics Operations, Inc. (previously named Lenz Therapeutics, Inc.), a Delaware corporation (\"LENZ OpCo\"), in exchange of outstanding shares of LENZ OpCo, pursuant to the terms and conditions of the Merger Agreement."}],"balance_after":95034,"source":{"system":"sec-edgar","filing":"0001815776-24-000028","document":"wk-form4_1711413733.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815776/000181577624000028/wk-form4_1711413733.xml","form_type":"4"}}]}